SEARCH

SEARCH BY CITATION

References

  • 1
    Gluckman E, Rocha V, Chastang C. Cord blood banking and transplant in Europe. Eurocord. Bone Marrow Transplant 1998; 22: 6874.
  • 2
    Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 15651577.
  • 3
    Kurtzberg J, Laughlin M, Graham M, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157166.
  • 4
    Migliaccio A, Adamson J, Stevens C, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 27172722.
  • 5
    Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996; 2: 13291337.
  • 6
    Pflumio F, Izac B, Katz A, et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996; 88: 37313740.
  • 7
    Conneally E, Cashman J, Petzer A, et al. Expansion in vitro of transplantable human cord blood stem cells demontrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997; 94: 98369841.
  • 8
    Cashman J, Bockhold K, Hogge D, et al. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human hematopoietic cells in NOD/SCID mice transplanted with human cord blood. Br J Haematol 1997; 98: 10261036.
  • 9
    Cashman J, Lapidot T, Wang J, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997; 89: 43074316.
  • 10
    Bhatia M, Bonnet D, Kapp U, et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619624.
  • 11
    Shpall E, Quinones R, Hami L, et al. Transplantation of cancer patients receiving high dose chemotherapy with ex vivo expanded cord blood cells. Blood 1998; 92 (suppl 1):2667a.
  • 12
    Gluckman E, Rocha V, Chastang C. Cord blood stem cell transplantation. Baillieres Best Pract Res Clin Haematol 1999; 12: 279292.
  • 13
    Gan O, Murdoch B, Larochelle A, et al. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 1997; 90: 641650.
  • 14
    Holyoake T, Alcorn M, Richmond L, et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997; 19: 10951101.
  • 15
    Möbest D, Goan S-R, Junghahn I, et al. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Stem Cells 1999; 17: 152161.
  • 16
    Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 28442853.
  • 17
    Kimura T, Sakabe H, Tanimukai S, et al. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Blood 1997; 90: 47674778.
  • 18
    Miller J, McCullar V, Verfaillie C. Ex vivo culture of CD34+/Lin/DR cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1 alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood 1998; 91: 45164522.
  • 19
    Yonemura Y, Ku H, Hirayama F, et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996; 93: 40404044.
  • 20
    Matsunaga T, Hirayama F, Yonemura Y, et al. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by beta-c and beta-IL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood 1998; 92: 901907.
  • 21
    Bryder D, Jacobsen S. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 2000; 96: 17481755.
  • 22
    Miller C, Eaves C. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 1998; 94: 1364813653.
  • 23
    Oostendorp R, Audet J, Eaves C. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000; 95: 855862.
  • 24
    Ohmizono Y, Sakabe H, Kimura T, et al. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand. Leukemia 1997; 11: 524530.
  • 25
    Kobayashi M, Laver J, Kato T, et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 1996; 88: 429436.
  • 26
    Petzer AL, Zandstra PW, Piret JM, et al. Differential cytokine effects on primitive (CD34+CD38) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoetin. J Exp Med 1996; 183: 25512558.
  • 27
    Shah A, Smogorzewska E, Hannum C, et al. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38 cells and maintains progenitor cells in vitro. Blood 1996; 87: 35633570.
  • 28
    Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 26442653.
  • 29
    Hirayama F, Clark S, Ogawa M. Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha. Proc Natl Acad Sci USA 1994; 91: 469473.
  • 30
    Guenechea G, Segovia J, Albella B, et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34+ cord blood cells. Blood 1999; 93: 10971105.
  • 31
    Novelli E, Cheng L, Yang Y, et al. Ex vivo culture of cord blood CD34+ cells expands progenitor cells numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency. Hum Gene Ther 1999; 10: 29272940.
  • 32
    Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 2000; 105: 10131021.
  • 33
    Shimizu Y, Ogawa M, Kobayashi M, et al. Engraftment of cultured human hematopoietic cells in sheep. Blood 1998; 91: 36883692.
  • 34
    Glimm H, Eaves C. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 1999; 94: 21612168.
  • 35
    Hennemann B, Conneally E, Pawliuk R, et al. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Exp Hematol 1999; 27: 817825.
  • 36
    Zandstra P, Conneally E, Petzer A, et al. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 1997; 94: 46984703.
  • 37
    Ladd A, Pyatt R, Gothot A, et al. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood 1997; 90: 658668.
  • 38
    Möhle R, Bautz F, Rafii S, et al. The chemokine receptor CXCR4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal derived factor-1. Blood 1998; 91: 45234530.
  • 39
    Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845848.
  • 40
    Jo D-Y, Rafii S, Hamada T, et al. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest 2000; 105: 101111.